Journal of Pain and Symptom Management
Volume 39, Issue 2 , Pages e1-e5 , February 2010

Re: Update on Cancer Pain Guidelines

References 

  1. Caraceni A, de Conno F, Kaasa S, Radbruch L, Hanks G. Update on cancer pain guidelines. J Pain Symptom Manage. 2009;38:e1–e3
  2. Wiffen P, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2007;(4):CD003868
  3. Good PD, Ravenscroft PJ, Cavenagh J. Effects of opioids and sedatives on survival in an Australian inpatient palliative care population. Intern Med J. 2005;35:512–517
  4. Wilcock A, Chauhan A. Benchmarking the use of opioids in the last days of life. J Pain Symptom Manage. 2007;34:1–3
  5. Thorns A, Sykes N. Opioid use in last week of life and implications for end-of-life decision-making. Lancet. 2000;356:398–399
  6. Challand S, Frew K. Benchmarking the use of opioids. J Pain Symptom Manage. 2008;35:456
  7. NHS Patient Safety Agency. Ensuring safer practice with high dose ampoules of diamorphine and morphine. Safer Practice Notice, no. 12, May 25, 2006.
  8. NHS Patient Safety Agency. Reducing dosing errors with opioid medicines. Rapid Response Report NPSA/2008/RRR05, July 4, 2008.
  9. NHS Patient Safety Agency. Reducing dosing errors with opioid medicines: supporting information. Rapid Response Report NPSA/2008/RRR05, July 2008.
  10. Medicines and Healthcare Products Agency (MHRA) . Fentanyl patches: serious and fatal overdose from dosing errors, accidental exposure, and inappropriate use. Drug Saf Update. 2008;2(2):2–3
  11. Dyer C. GMC clears doctors on accidental morphine overdose. BMJ. 1999;318:1167
  12. Dyer C. Inquest begins into deaths after concerns about diamorphine prescribing. BMJ. 2009;338:903
  13. GMC Fitness to Practice Panel. Available from: http://gmc-uk.org/static/documents/content/Macklin_(H)_Minutes_ANON_18–22May09.pdf Accessed November 1, 2009.
  14. Weinstein SM, Laux LF, Thornby JI, et al. Physicians' attitudes toward pain and the use of opioid analgesics: results of a survey from the Texas Cancer Pain Initiative. South Med J. 2000;93:479–487
  15. Larue F, Colleau SM, Fontaine A, Brasseur L. Oncologists and primary care physicians' attitudes toward pain control and morphine prescribing in France. Cancer. 1995;76:2375–2382
  16. Anonymous. . Shipman inquiry. Fifth report: safeguarding patients, lessons from the past—proposals for the future. Available from www.the-shipman-inquiry.org.uk2004;
  17. Fallon M, Hanks GW. ABC of palliative care. 2nd ed.. Oxford, United Kingdom: Blackwell Publishing; 2006;
  18. Regnard C, Dean M. A guide to symptom relief in palliative care. 6th ed.. Oxford, United Kingdom: Radcliffe Press; 2010;
  19. Joint Formulary Committee . British National Formulary. 57th ed.. London, United Kingdom: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2009;
  20. In:  Davies A editors. Cancer related breakthrough pain. Oxford, United Kingdom: Oxford University Press; 2006;p. 31–56
  21. Ellershaw J, Wilkinson S. Care of the dying: A pathway to excellence. Oxford, United Kingdom: Oxford University Press; 2003;52–53
  22. Regnard C, Kindlen M. Using morphine. (2008) Available from: http://www.helpthehospices.org.uk/clip.
  23. Hanks GW, De Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001;84:587–593
  24. Sykes N, Edmonds P, Wiles J. Management of advanced disease. 4th ed.. London, United Kingdom: Arnold; 2004;
  25. Gowans J. MIMS (Monthly Index of Medical Specialties). London, United Kingdom: Haymarket Medical Media; 2008;
  26. Doyle D, Hanks GW, Cherny N, Calman K. Oxford textbook of palliative medicine. 3rd ed.. Oxford, United Kingdom: Oxford University Press; 2004;
  27. Stannard C, Booth S. Pain pocketbook. 2nd ed.. Edinburgh, United Kingdom: Churchill Livingstone; 2004;45–62
  28. Twycross R, Wilcock A. Palliative Care Formulary. 3rd ed.. Oxford, United Kingdom: Radcliffe Press; 2008;Available from www.palliativedrugs.com
  29. Back IN. Palliative medicine handbook. 4th ed.. Cardiff, Wales, United Kingdom: BPM Books; 2008;Available from http://book.pallcare.info
  30. SIGN (Scottish Intercollegiate Guidelines Network) . Control of pain in adults with cancer. Guideline No. 106 Edinburgh, United Kingdom: SIGN; 2008;Available from www.sign.ac.uk
  31. Twycross R, Wilcock A, Stark Toller C. Symptom management in advanced cancer. 4th ed.. Nottingham, United Kingdom: palliativedrugs.com; 2009;
  32. Joint Formulary Committee . British National Formulary. 58th ed.. London, United Kingdom: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2009;
  33. Quigley C. The role of opioids in cancer pain. BMJ. 2005;331:825–829
  34. Brooks DJ, Gamble W, Ahmedzai S. A regional survey of opioid use by patients receiving specialist palliative care. Palliat Med. 1995;9:229–238
  35. Walsh TD, Cheater FM. Use of morphine for cancer pain. Pharmaceutical Journal. 1983;231:525–528

PII: S0885-3924(09)01135-X

doi: 10.1016/j.jpainsymman.2009.11.240

Journal of Pain and Symptom Management
Volume 39, Issue 2 , Pages e1-e5 , February 2010

Article Tools